Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Ixazomib for Multiple Myeloma
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial study looks at the effects of ixazomib citrate on patients with multiple myeloma who have had a relapse, but are still responsive to bortezomib. Ixazomib citrate may prevent cancer cell growth by blocking some of the enzymes necessary for cell growth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service